Indian pharma industry is now likely to clock 12-13 per cent growth in 2009 against earlier projections of 15 per cent due to the global economic meltdown, a research firm said.
"In 2009, the Indian pharma industry may see a growth of 12-13 per cent, as against our earlier forecast of 14-15 per cent, due to the macroeconomic condition that we are having," ORG IMS Research Managing Director Sameer Savkur said at a conference here.
Mumbai-based ORG IMS Research is a joint venture of AC Nielsen ORG-Marg and IMS Health, UK.
"Global pharma growth has been declining in the past five years. There is only a small impact on India. It will see double-digit topline growth," IMS Health UK Vice President Europe Graham Lewis said.
Lewis said there has been a significant amount of restructuring in the global pharmaceutical industry, with smaller companies running out of cash and bigger companies merging with each other.
The Indian pharma industry, which grew over 10 per cent last year, is likely to see a marginal one-to-two per cent spurt in growth in the next four to five years, Savkur said.
Also Read
The industry witnessed a growth of only 10.2 per cent in 2008 due to some extraneous circumstances, he said.
He, however, termed the Indian pharmaceutical industry as "promising", and estimated its size to touch $30 billion by 2020.
Chronic therapy will continue to be a key growth driver, Savkur said, adding that companies are focusing on extra-urban markets as these contribute about 40 per cent to their turnover.